We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Innovaderma Plc | LSE:IDP | London | Ordinary Share | GB00BT9PTW34 | ORD EUR0.10 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 29.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMIDP
RNS Number : 2919Y
InnovaDerma PLC
11 May 2021
InnovaDerma PLC
("InnovaDerma" or the "Company")
Director/PDMR shareholding
InnovaDerma (LSE: IDP), a UK developer of beauty, personal care and life sciences products, announces that it was notified on 10 May 2021, Mark Ward, Non-executive Director has purchased as part of the Company's Open Offer, 17,500 Ordinary Shares of EUR0.10 each in the Company at a price of 35 pence per Ordinary Share.
Following the purchase, Mark Ward now holds a total of 3,791,990 Ordinary Shares representing approximately 13.85% of the issued share capital of the Company.
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.
Further enquiries
InnovaDerma Blake Hughes c/o TB Cardew finnCap Ltd Geoff Nash/Kate Bannatyne +44 (0)207 220 0500 Alice Lane - Corporate Broking www.finncap.com -------------------------- TB Cardew Shan Shan Willenbrock/ + 44 (0)7775 848537 Olivia Rosser + 44 (0)20 7930 0777 innovaDerma@tbcardew.com --------------------------
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1. Details of the person discharging managerial responsibilities / person closely associated a) Name Mark Ward -------------------------------- --------------------------------- 2. Reason for the Notification ------------------------------------------------------------------- a) Position/status Non-executive Director -------------------------------- --------------------------------- b) Initial notification/Amendment Initial notification -------------------------------- --------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ------------------------------------------------------------------- a) Name InnovaDerma PLC -------------------------------- --------------------------------- b) LEI 213800WRAP6W8VDL6B38 -------------------------------- --------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ------------------------------------------------------------------- a) Description of the EUR0.10 each ("Ordinary Shares") Financial instrument, type of instrument Identification code IDP GB00BT9PTW34 -------------------------------- --------------------------------- b) Nature of the transaction Purchase of Ordinary Shares -------------------------------- --------------------------------- c) Price(s) and volume(s) Volume - 17,500 Ordinary Shares Price - 35 pence per Ordinary Share -------------------------------- --------------------------------- d) Aggregated information: Aggregated volume See 4c) above Price -------------------------------- --------------------------------- e) Date of the transaction 30 April 2021 -------------------------------- --------------------------------- f) Place of the transaction London Stock Exchange, Main Market -------------------------------- ---------------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHUAABRASUVAAR
(END) Dow Jones Newswires
May 11, 2021 13:15 ET (17:15 GMT)
1 Year Innovaderma Chart |
1 Month Innovaderma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions